Structures by: Goswami S.
Total: 311
C38H37ClN5O3Pd,0.5(Cl4Pd),0.44(Cl2Pd),H2O
C38H37ClN5O3Pd,0.5(Cl4Pd),0.44(Cl2Pd),H2O
Chem.Commun. (2011) 47, 9101
a=21.8033(4)Å b=16.4269(3)Å c=22.7565(5)Å
α=90.00° β=103.155(1)° γ=90.00°
C28H33N5O6
C28H33N5O6
RSC Adv. (2014)
a=21.4456(4)Å b=11.4678(2)Å c=11.4003(3)Å
α=90.00° β=107.9100(10)° γ=90.00°
C42H39N5O3S
C42H39N5O3S
RSC Advances (2014)
a=20.0319(9)Å b=14.3160(6)Å c=24.1507(9)Å
α=90.00° β=90.00° γ=90.00°
C30H30Cu3N28O2
C30H30Cu3N28O2
CrystEngComm (2014) 16, 3 369
a=12.9517(17)Å b=14.733(2)Å c=20.052(3)Å
α=90.00° β=129.256(8)° γ=90.00°
C15H11CoN2O6S2
C15H11CoN2O6S2
CrystEngComm (2014) 16, 22 4742
a=15.7239(19)Å b=16.158(2)Å c=40.866(10)Å
α=90.00° β=90.00° γ=90.00°
C30H18CuN4O8S4,2(O)
C30H18CuN4O8S4,2(O)
CrystEngComm (2014) 16, 22 4742
a=8.315(2)Å b=10.205(3)Å c=20.279(5)Å
α=90.00° β=113.120(12)° γ=90.00°
2(C15H9N2NiO6S2),2(C2O),11(O)
2(C15H9N2NiO6S2),2(C2O),11(O)
CrystEngComm (2014) 16, 22 4742
a=15.8979(12)Å b=15.7892(12)Å c=20.3288(16)Å
α=90.00° β=106.324(8)° γ=90.00°
2(C12H15N5O2),3(C7H6O3)
2(C12H15N5O2),3(C7H6O3)
CrystEngComm (2010) 12, 5 1501
a=16.0828(9)Å b=6.8716(3)Å c=24.8286(14)Å
α=90.00° β=121.643(4)° γ=90.00°
C14H19N5O4,C7H6O3
C14H19N5O4,C7H6O3
CrystEngComm (2010) 12, 5 1501
a=6.9162(3)Å b=22.0035(9)Å c=14.3569(5)Å
α=90.00° β=90.319(2)° γ=90.00°
C32H26N10Ni2O2
C32H26N10Ni2O2
Dalton transactions (Cambridge, England : 2003) (2014) 43, 45 16996-16999
a=11.4696(4)Å b=11.6432(5)Å c=13.4883(5)Å
α=84.488(2)° β=82.801(2)° γ=61.108(2)°
C34H36CdCl2N8O2,2(H2O)
C34H36CdCl2N8O2,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 9 4123-4132
a=18.0309(4)Å b=10.7197(4)Å c=20.3059(6)Å
α=90.00° β=111.574(2)° γ=90.00°
C17H18N4O
C17H18N4O
Dalton transactions (Cambridge, England : 2003) (2015) 44, 9 4123-4132
a=5.9895(4)Å b=14.7978(8)Å c=17.8142(14)Å
α=90.00° β=96.481(6)° γ=90.00°
C12H15Co3N9O18,6.5(O)
C12H15Co3N9O18,6.5(O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 9 3949-3953
a=14.2040(9)Å b=14.2040(9)Å c=15.0369(10)Å
α=90° β=90° γ=90°
C12H11Fe3N9O18,0.075(O4),6.201(O)
C12H11Fe3N9O18,0.075(O4),6.201(O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 9 3949-3953
a=14.300(4)Å b=14.300(4)Å c=14.983(4)Å
α=90° β=90° γ=90°
C23H27DyN6O10,2(NO3),H2O
C23H27DyN6O10,2(NO3),H2O
Dalton transactions (Cambridge, England : 2003) (2015) 44, 11 5086-5094
a=10.1352(7)Å b=15.3564(13)Å c=10.6736(8)Å
α=90.00° β=109.060(3)° γ=90.00°
C23H20DyN6O9,NO3
C23H20DyN6O9,NO3
Dalton transactions (Cambridge, England : 2003) (2015) 44, 11 5086-5094
a=8.073(3)Å b=11.659(4)Å c=16.832(5)Å
α=85.771(5)° β=85.202(7)° γ=86.025(6)°
C22H32Cl4Cu2N4O2
C22H32Cl4Cu2N4O2
Dalton transactions (Cambridge, England : 2003) (2015) 44, 19 8876-8888
a=9.1653(5)Å b=7.2194(4)Å c=20.4311(11)Å
α=90.00° β=93.455(2)° γ=90.00°
C76H142Co5Gd3N2O33,2(O)
C76H142Co5Gd3N2O33,2(O)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 39 14577-14585
a=14.2172(9)Å b=27.711(2)Å c=25.4221(17)Å
α=90.00° β=96.1053(19)° γ=90.00°
C74H136Co5Dy3N2O33,2(O),2(CH3)
C74H136Co5Dy3N2O33,2(O),2(CH3)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 39 14577-14585
a=14.1684(7)Å b=27.6583(16)Å c=25.4178(13)Å
α=90.00° β=96.0392(15)° γ=90.00°
C54H105Co3Gd3N3O25,2(NO3),2(O)
C54H105Co3Gd3N3O25,2(NO3),2(O)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 39 14577-14585
a=14.900(3)Å b=31.505(5)Å c=19.332(3)Å
α=90° β=103.363(4)° γ=90°
2-Amino-6-hydroxymethylpyridine
C6H8N2O
Acta Crystallographica Section E (2006) 62, 8 o3225-o3227
a=6.9279(2)Å b=4.75700(10)Å c=19.3436(5)Å
α=90.00° β=92.657(2)° γ=90.00°
DMAP perchlorate salt
C7H11N2,ClO4
Acta Crystallographica Section E (2005) 61, 11 o3733-o3734
a=8.14290(10)Å b=14.8202(2)Å c=10.44930(10)Å
α=90.00° β=128.7710(10)° γ=90.00°
2-Pivaloyl-2-amino-6-hydroxymethylpyridine
C11H16N2O2
Acta Crystallographica Section E (2005) 61, 1 o105-o107
a=6.8330(6)Å b=10.3313(10)Å c=16.1635(15)Å
α=90.00° β=94.486(2)° γ=90.00°
2-Aminopyrimidine-Fumaric Acid (1:2) co-crystal
C8H9N3O4
Acta Crystallographica Section C (1999) 55, 4 583-585
a=3.7946(2)Å b=19.1766(7)Å c=13.0641(6)Å
α=90.00° β=96.8930(10)° γ=90.00°
2-Acetylamino-6-methylpyridine N-oxide monohydrate
C8H12N2O3
Acta Crystallographica Section C (1999) 55, 4 579-581
a=7.1276(6)Å b=7.8860(6)Å c=8.9938(7)Å
α=100.143(2)° β=91.493(2)° γ=110.9720(10)°
C13H13NO3S
C13H13NO3S
Acta Crystallographica Section C (1998) 54, 9 1301-1302
a=23.9096(7)Å b=9.5192(3)Å c=11.9629(3)Å
α=90.00° β=112.1360(10)° γ=90.00°
2-anilinyl-4-toluenesulfonate
C13H13NO3S
Acta Crystallographica Section C (1998) 54, 7 954-955
a=9.9807(7)Å b=7.5585(6)Å c=17.0244(12)Å
α=90.00° β=90.196(7)° γ=90.00°
5-Nitroisophthalic acid hydrate
C8H7NO7
Acta Crystallographica Section C (1999) 55, 11 1845-1847
a=28.1940(10)Å b=9.5793(4)Å c=6.9050(3)Å
α=90.00° β=90.00° γ=90.00°
O-Phenylenediamine and Pyrocatechol (1:1) monohydrate complex
C6H8N2,C6H6O2,0.5H2O
Acta Crystallographica Section C (1998) 54, 11 1647-1649
a=9.0498(2)Å b=5.22750(10)Å c=25.0771(2)Å
α=90.00° β=97.71° γ=90.00°
2-Aminopyrimidine and p-phenylenediacetic acid
C14H15N3O4
Acta Crystallographica Section C (1999) 55, 3 399-401
a=4.56860(10)Å b=15.7687(2)Å c=20.1621(4)Å
α=90.00° β=90.00° γ=90.00°
2-Aminopyrimidine-Terephthalic acid (1:1) complex
C4H5N3.C8H6O4
Acta Crystallographica Section C (1999) 55, 1 87-89
a=13.0323(3)Å b=23.94430(10)Å c=3.79270(10)Å
α=90.00° β=90.00° γ=90.00°
2,7-bis(methoxycarbonylmethoxy)naphtalene
C16H16O6
Acta Crystallographica Section E (2006) 62, 11 o5307-o5309
a=26.8936(4)Å b=6.67720(10)Å c=8.02890(10)Å
α=90.00° β=91.1980(10)° γ=90.00°
<i>N</i>-(7-Dimethoxymethyl-4-oxo-3,4-dihydropteridin-2-yl)-2,2-dimethylpropionamide monohydrate
C14H19N5O4,H2O
Acta Crystallographica Section E (2007) 63, 11 o4249-o4250
a=11.9683(5)Å b=15.7252(6)Å c=8.9289(3)Å
α=90.00° β=94.998(2)° γ=90.00°
<i>N</i>,<i>N</i>'-Bis(pyrimidin-2-yl)terephthalamide dihydrate
C16H12N6O2,2H2O
Acta Crystallographica Section E (2008) 64, 1 o267-o268
a=5.07330(10)Å b=8.32330(10)Å c=9.9622(2)Å
α=68.2200(10)° β=75.4410(10)° γ=82.3330(10)°
N^2^,N^2'^-Bis(2,2-dimethylpropanoyl)benzene-1,3-dicarbohydrazide
C18H26N4O4
Acta Crystallographica Section E (2008) 64, 1 o175-o176
a=7.1853(2)Å b=14.8928(4)Å c=17.1656(5)Å
α=90.00° β=96.050(2)° γ=90.00°
2-(7-Hydroxy-2-naphthyloxy)-<i>N</i>-(6-methyl-2-pyridyl)acetamide
C18H16N2O3
Acta Crystallographica Section E (2008) 64, 4 o699
a=5.3676(3)Å b=11.6991(7)Å c=12.2915(6)Å
α=104.994(4)° β=94.777(3)° γ=94.877(4)°
3-Benzoyl-2,4-bis(3-bromophenyl)cyclobutyl phenyl ketone
C30H22Br2O2
Acta Crystallographica Section E (2007) 63, 2 o1069-o1070
a=5.78130(10)Å b=14.6794(2)Å c=14.2828(2)Å
α=90.00° β=102.9880(10)° γ=90.00°
1,4-phenylenediacetic acid
C10H10O4
Acta Crystallographica Section E (2007) 63, 7 o3171-o3171
a=10.2747(4)Å b=4.7218(2)Å c=10.1686(4)Å
α=90.00° β=116.220(2)° γ=90.00°
A second monoclinic polymorph of 2-amino-4,6-dichloropyrimidine
C4H3Cl2N3
Acta Crystallographica Section E (2008) 64, 9 o1659-o1660
a=32.060(4)Å b=3.8045(6)Å c=21.302(3)Å
α=90.00° β=102.193(7)° γ=90.00°
Bis(2,1,3-benzoselenadiazole-κN)dichloridozinc(II)
C12H8Cl2N4Se2Zn
Acta Crystallographica Section E (2008) 64, 9 m1188
a=7.5593(2)Å b=9.7269(3)Å c=10.6083(3)Å
α=95.1030(10)° β=92.5810(10)° γ=101.7130(10)°
4,6-Diphenyl-pyrimidin-2-yl-amine
C16H13N3
Acta Crystallographica Section E (2006) 62, 11 o5332-o5334
a=18.8775(6)Å b=7.3316(2)Å c=21.3634(7)Å
α=90.00° β=123.413(2)° γ=90.00°
3-Methylquinoxaline-2-carbonitrile
C10H7N3
Acta Crystallographica Section E (2007) 63, 4 o1741-o1742
a=6.869(2)Å b=7.417(3)Å c=9.879(5)Å
α=72.37(4)° β=71.82(3)° γ=64.29(3)°
5-Bromo-5-bromomethyl-2-phenoxy-1,3,2-dioxaphosphorinan-2-one
C10H11Br2O4P
Acta Crystallographica Section E (2008) 64, 11 o2228-o2229
a=12.1315(3)Å b=6.30950(10)Å c=16.8901(3)Å
α=90.00° β=92.196(2)° γ=90.00°
4,6-diphenyl-2-pyrimidinylamine
C16H13N3
Acta Crystallographica Section C (2004) 60, 4 o229-o231
a=7.8263(9)Å b=10.8009(9)Å c=15.7878(12)Å
α=83.457(5)° β=77.039(7)° γ=82.326(7)°
Self-assembly of 2-pivaloylchloropterin
C11H12ClN5O2
Acta Crystallographica Section C (2000) 56, 6 716-717
a=13.5984(5)Å b=9.6927(3)Å c=10.3211(4)Å
α=90.00° β=108.9810(10)° γ=90.00°
1:1 Hetero-assembly of 2-Aminopyrimidine and (+)-Camphoric acid
C4H5N3,C10H16O4
Acta Crystallographica Section C (2000) 56, 4 477-478
a=7.1460(10)Å b=10.5610(10)Å c=21.3060(10)Å
α=90.00° β=90.00° γ=90.00°
N-(6-Bromo-4-oxo-3,4-dihydropteridin-2-yl)-2,2-dimethylpropanamide
C11H12BrN5O2
Acta Crystallographica Section C (2000) 56, 7 e302-e303
a=13.43150(10)Å b=10.3779(2)Å c=10.2560(2)Å
α=90.00° β=106.2160(10)° γ=90.00°
<i>N</i>-[6-(Dibromomethyl)-2-pyridyl]-2,2-dimethylpropionamide
C11H14Br2N2O
Acta Crystallographica Section E (2009) 65, 4 o725
a=13.2936(7)Å b=8.4660(3)Å c=11.9638(6)Å
α=90° β=99.195(3)° γ=90°
7-Nitro-1,2,3,4-tetrahydronaphthalene-1-spiro-2'-(1,3-dithiane)
C13H15NO2S2
Acta Crystallographica Section E (2009) 65, 2 o347
a=12.86730(10)Å b=42.2330(6)Å c=9.18190(10)Å
α=90° β=90° γ=90°
2-(4-Nitrophenyl)-1,3-dithiane
C10H11NO2S2
Acta Crystallographica Section E (2009) 65, 2 o348
a=8.77240(10)Å b=10.20790(10)Å c=11.99420(10)Å
α=90° β=90° γ=90°
2-Pyrene-1-yl-[1,3]dithiane
C20H16S2
Acta Crystallographica Section E (2009) 65, 4 o891
a=7.14240(10)Å b=8.60160(10)Å c=24.5049(2)Å
α=90.00° β=90.00° γ=90.00°
2,7-bis(trichloromethyl)-1,8-naphthyridine
C10H4Cl6N2
Acta Crystallographica Section E (2010) 66, 3 o622
a=19.9154(4)Å b=6.59770(10)Å c=10.5975(2)Å
α=90.00° β=111.483(2)° γ=90.00°
<i>N</i>-(6-Bromomethyl-2-pyridyl)acetamide
C8H9BrN2O
Acta Crystallographica Section E (2010) 66, 10 o2500
a=4.1894(8)Å b=26.219(5)Å c=23.817(4)Å
α=90.00° β=94.148(4)° γ=90.00°
2-(1,3-Dithian-2-yl)-1,3-dithiane-2-carbaldehyde
C9H14OS4
Acta Crystallographica Section E (2009) 65, 1 o173
a=13.0028(2)Å b=13.6790(2)Å c=13.4244(2)Å
α=90.00° β=91.8730(10)° γ=90.00°
Guanidinium chlorochromate
CH6N3,ClCrO3
Acta Crystallographica Section E (2010) 66, 2 m203
a=5.9708(2)Å b=7.5302(2)Å c=14.7085(4)Å
α=90.00° β=90.00° γ=90.00°
2-Amino-3,5-dichloro-6-methylpyridine
C6H6Cl2N2
Acta Crystallographica Section E (2009) 65, 1 o97
a=12.7670(3)Å b=3.80370(10)Å c=15.4129(3)Å
α=90° β=104.9900(10)° γ=90°
2-Iodo-<i>N</i>-(6-methyl-2-pyridyl)benzamide
C13H11IN2O
Acta Crystallographica Section E (2009) 65, 1 o118-o119
a=9.8687(3)Å b=10.1276(3)Å c=13.6366(4)Å
α=97.5210(10)° β=93.1130(10)° γ=110.3800(10)°
7-(2,2-Dimethylpropanamido)-2-methyl-1,8-naphthyridin-1-ium chloride monohydrate
C14H18N3O,Cl,H2O
Acta Crystallographica Section E (2009) 65, 2 o340
a=19.0092(5)Å b=9.0077(2)Å c=17.7294(5)Å
α=90.00° β=90.00° γ=90.00°
1,2-Di-2-quinolylethene
C20H14N2
Acta Crystallographica Section E (2009) 65, 2 o354
a=15.6378(2)Å b=6.07980(10)Å c=16.0860(2)Å
α=90.00° β=108.8790(10)° γ=90.00°
2,4-Diphenyl-4,5-dihydro-3<i>H</i>-pyrido[2,3-b][1,4]diazepine
C20H17N3
Acta Crystallographica Section E (2009) 65, 5 o1139-o1140
a=5.9969(3)Å b=15.3186(6)Å c=17.0676(7)Å
α=82.588(3)° β=85.266(2)° γ=88.670(2)°
6-Amino-2,5-bis(pivaloylamino)pyrimidin-4(3<i>H</i>)-one dihydrate
C14H23N5O3,2(H2O)
Acta Crystallographica Section E (2009) 65, 7 o1484-o1485
a=7.5560(3)Å b=14.1008(6)Å c=18.0713(6)Å
α=71.079(2)° β=89.988(2)° γ=86.682(3)°
2,7-Dimethyl-1,8-naphthyridine
C10H10N2
Acta Crystallographica Section E (2009) 65, 8 o1747
a=13.3977(2)Å b=19.3492(4)Å c=6.30890(10)Å
α=90.00° β=90.00° γ=90.00°
Quinoxaline-2-carbonitrile
C9H5N3
Acta Crystallographica Section E (2010) 66, 1 o28
a=3.80550(10)Å b=19.0466(4)Å c=10.1845(2)Å
α=90.00° β=93.4660(10)° γ=90.00°
2,9-Bis(trichloromethyl)-1,10-phenanthroline
C14H6Cl6N2
Acta Crystallographica Section E (2010) 66, 2 o424
a=24.3001(6)Å b=6.8825(2)Å c=20.3461(5)Å
α=90.00° β=114.6890(10)° γ=90.00°
<i>N</i>-Butyl-4-methyl-6-phenylpyrimidin-2-amine
C15H19N3
Acta Crystallographica Section E (2010) 66, 4 o866
a=13.4828(9)Å b=5.1618(3)Å c=22.8462(11)Å
α=90.00° β=123.863(3)° γ=90.00°
1,10-Phenanthroline--dithiooxamide (2/1)
C12H8N2,0.5(C2H4N2S2)
Acta Crystallographica Section E (2010) 66, 6 o1320
a=10.5481(3)Å b=10.0544(3)Å c=13.9960(4)Å
α=90.00° β=130.145(2)° γ=90.00°
<i>N</i>-(6-{2-[6-(2,2-Dimethylpropanamido)-2-pyridyl]ethyl}-2-pyridyl)-2,2- dimethylpropanamide
C22H30N4O2
Acta Crystallographica Section E (2010) 66, 8 o1960-o1961
a=11.7933(3)Å b=10.3648(2)Å c=17.8667(4)Å
α=90.00° β=90.00° γ=90.00°
Adeninium perchlorate
C5H6N5,ClO4
Acta Crystallographica Section E (2011) 67, 2 o427
a=8.7614(2)Å b=4.82340(10)Å c=21.0758(4)Å
α=90.00° β=112.0700(10)° γ=90.00°
(<i>Z</i>)-1,2-Dichloro-1,2-bis(3-chloroquinoxalin-2-yl)ethene
C18H8Cl4N4
Acta Crystallographica Section E (2011) 67, 2 o290
a=19.0972(5)Å b=10.9883(3)Å c=8.1905(2)Å
α=90.00° β=90.7820(10)° γ=90.00°
Bis(2,1,3-benzoselenadiazole-κ<i>N</i>)dibromidocopper(II)
C12H8Br2Cu1N4Se2
Acta Crystallographica Section E (2011) 67, 2 m181-m182
a=8.34060(10)Å b=9.58530(10)Å c=10.29080(10)Å
α=94.6270(10)° β=109.6400(10)° γ=102.6900(10)°
<i>N</i>-Butyl-4,6-diphenylpyrimidin-2-amine
C20H21N3
Acta Crystallographica Section E (2011) 67, 11 o2956
a=8.15440(10)Å b=9.52840(10)Å c=11.3237(2)Å
α=77.0900(10)° β=74.1520(10)° γ=71.2880(10)°
Methyl pyrido[2,3-<i>b</i>]pyrazine-3-carboxylate
C9H7N3O2
Acta Crystallographica Section E (2011) 67, 11 o3120
a=9.51350(10)Å b=26.9042(3)Å c=6.78370(10)Å
α=90.00° β=107.6860(10)° γ=90.00°
<i>N</i>-Benzyl-4-methyl-6-phenylpyrimidin-2-amine
C18H17N3
Acta Crystallographica Section E (2011) 67, 11 o2932
a=8.29740(10)Å b=9.9316(2)Å c=10.7251(2)Å
α=115.7970(10)° β=93.0190(10)° γ=111.5650(10)°
Ethyl 7-pivaloylamino-1,8-naphthyridine-2-carboxylate sesquihydrate
C16H19N3O3,1.5(H2O)
Acta Crystallographica Section E (2011) 67, 12 o3415
a=30.7759(7)Å b=7.2406(2)Å c=16.9271(4)Å
α=90.00° β=120.0090(10)° γ=90.00°
Ethyl 2-[(2-oxo-2<i>H</i>-chromen-7-yl)oxy]acetate
C13H12O5
Acta Crystallographica Section E (2013) 69, 4 o502
a=8.1435(2)Å b=16.4887(4)Å c=10.5506(3)Å
α=90.00° β=125.882(2)° γ=90.00°
7-Hydroxymethyl-2-pivaloylamino-1,8-naphthyridine
C14H17N3O2
Acta Crystallographica Section E (2013) 69, 4 o503
a=14.7026(3)Å b=6.25860(10)Å c=14.7035(3)Å
α=90.00° β=97.447(2)° γ=90.00°
Bis{2-[(5-hydroxypentyl)iminomethyl]phenolato-κ^2^<i>N</i>,<i>O</i>^1^}copper(II)
C24H32CuN2O4
Acta Crystallographica Section E (2013) 69, 7 m412-m413
a=11.8815(8)Å b=5.2219(3)Å c=18.9588(12)Å
α=90.00° β=102.876(2)° γ=90.00°
0.67(C36H24Cl4N18Zn4.9)
0.67(C36H24Cl4N18Zn4.9)
Chemistry of Materials (2020) 32, 16 6998-7004
a=10.009(4)Å b=16.663(8)Å c=14.610(6)Å
α=90° β=106.65(3)° γ=90°
C44H34Cu2I2N6O2,2(C5H5N)
C44H34Cu2I2N6O2,2(C5H5N)
Chemistry of Materials (2015) 27, 15 5349
a=12.5823(8)Å b=13.5440(8)Å c=17.5152(11)Å
α=68.665(2)° β=89.462(2)° γ=64.914(2)°
C22H17CuIN3O,C2H3N3
C22H17CuIN3O,C2H3N3
Chemistry of Materials (2015) 27, 15 5349
a=24.404(3)Å b=12.3305(14)Å c=17.9345(19)Å
α=90.00° β=113.070(6)° γ=90.00°
C22H17CuIN3O,C6H5,NO2
C22H17CuIN3O,C6H5,NO2
Chemistry of Materials (2015) 27, 15 5349
a=24.260(3)Å b=12.6267(12)Å c=17.8971(17)Å
α=90.00° β=113.860(5)° γ=90.00°
C22H17CuIN3O,C2H6OS
C22H17CuIN3O,C2H6OS
Chemistry of Materials (2015) 27, 15 5349
a=24.97(5)Å b=12.02(2)Å c=18.21(3)Å
α=90.00° β=113.50(3)° γ=90.00°
2(C22H17CuIN3O),C6H4Cl
2(C22H17CuIN3O),C6H4Cl
Chemistry of Materials (2015) 27, 15 5349
a=23.9138(9)Å b=12.8156(5)Å c=17.6360(6)Å
α=90.00° β=112.655(2)° γ=90.00°
2(C22H17CuIN3O),C10N2,C3N2,2(C)
2(C22H17CuIN3O),C10N2,C3N2,2(C)
Chemistry of Materials (2015) 27, 15 5349
a=24.5691(8)Å b=12.3170(4)Å c=18.0299(6)Å
α=90.00° β=114.046(2)° γ=90.00°
C22H17CuIN3O,CH4O,O,C
C22H17CuIN3O,CH4O,O,C
Chemistry of Materials (2015) 27, 15 5349
a=24.457(2)Å b=12.2391(11)Å c=18.0357(14)Å
α=90.00° β=113.779(5)° γ=90.00°
2(C22H17CuIN3O),C6H4Br
2(C22H17CuIN3O),C6H4Br
Chemistry of Materials (2015) 27, 15 5349
a=23.8814(10)Å b=12.9205(5)Å c=17.5755(7)Å
α=90.00° β=112.522(2)° γ=90.00°
2(C22H17CuIN3O),2(C4H7N2O),C
2(C22H17CuIN3O),2(C4H7N2O),C
Chemistry of Materials (2015) 27, 15 5349
a=24.448(3)Å b=12.4621(12)Å c=17.8907(19)Å
α=90.00° β=113.418(5)° γ=90.00°
C44H34Cu2I2N6O2,C6H5F,O
C44H34Cu2I2N6O2,C6H5F,O
Chemistry of Materials (2015) 27, 15 5349
a=12.681(3)Å b=13.340(3)Å c=17.761(4)Å
α=69.389(9)° β=89.016(10)° γ=63.400(9)°
2(C22H17CuIN3O),2(C3H7NO),O
2(C22H17CuIN3O),2(C3H7NO),O
Chemistry of Materials (2015) 27, 15 5349
a=24.1040(15)Å b=12.5390(8)Å c=17.9067(11)Å
α=90.00° β=113.374(3)° γ=90.00°
C27H20BrN3O3
C27H20BrN3O3
ACS Omega (2018) 3, 12 18646
a=16.0970(9)Å b=9.1111(5)Å c=17.2334(10)Å
α=90° β=114.177(2)° γ=90°
C75H60Gd2N2O22,(C3H7NO)
C75H60Gd2N2O22,(C3H7NO)
Crystal Growth & Design (2014) 14, 3 1287
a=31.517(12)Å b=14.882(4)Å c=28.494(8)Å
α=90.00° β=120.19(2)° γ=90.00°
C75H60Dy2N2O22,(C3H7NO)
C75H60Dy2N2O22,(C3H7NO)
Crystal Growth & Design (2014) 14, 3 1287
a=31.28(3)Å b=14.735(13)Å c=28.51(5)Å
α=90.00° β=120.13(5)° γ=90.00°
C88H44O32(NiC4B18)0.67O0.67
C88H44O32(NiC4B18)0.67O0.67
Journal of the American Chemical Society (2018) 140, 11 3871-3875
a=38.555(4)Å b=38.555(4)Å c=17.0605(19)Å
α=90° β=90° γ=120°
2(C18H17Cl2N5NiO),O2,O
2(C18H17Cl2N5NiO),O2,O
The Journal of organic chemistry (2018) 83, 15 7771-7778
a=28.39(2)Å b=8.148(7)Å c=20.029(16)Å
α=90° β=100.78(3)° γ=90°
C17H13N4,ClO4
C17H13N4,ClO4
Journal of Organic Chemistry (2010) 75, 2065-2068
a=10.6760(10)Å b=7.2285(7)Å c=20.9474(19)Å
α=90.00° β=94.570(3)° γ=90.00°
C17H12N4
C17H12N4
Journal of Organic Chemistry (2010) 75, 2065-2068
a=6.8173(12)Å b=6.7934(12)Å c=27.684(5)Å
α=90.00° β=93.392(5)° γ=90.00°
C18H14N4
C18H14N4
Journal of Organic Chemistry (2010) 75, 2065-2068
a=6.882(4)Å b=7.400(4)Å c=14.123(8)Å
α=98.660(17)° β=93.716(16)° γ=93.664(16)°
C36H27N5
C36H27N5
Journal of Organic Chemistry (2012) 77, 10249-10259
a=9.893(3)Å b=10.737(3)Å c=14.794(6)Å
α=103.294(9)° β=105.814(10)° γ=104.803(7)°
C36H23Cl4N5
C36H23Cl4N5
Journal of Organic Chemistry (2012) 77, 10249-10259
a=6.982(6)Å b=13.943(13)Å c=17.510(16)Å
α=67.10(3)° β=86.10(3)° γ=76.05(2)°
C30H21N4,CF3O3S,C2H3N
C30H21N4,CF3O3S,C2H3N
Journal of Organic Chemistry (2012) 77, 10249-10259
a=11.9726(17)Å b=7.6790(11)Å c=31.289(5)Å
α=90.00° β=94.058(4)° γ=90.00°